Related Experiment Video

Updated: Jun 25, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

cAMP/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models

Ramakrishnaiah Siddappa1, Winfried Mulder, Ilse Steeghs

  • 1Department of Tissue Regeneration, Institute for BioMedical Technology, University of Twente, Enschede , The Netherlands.

Tissue Engineering. Part A
|February 24, 2009
PubMed

Insights

Cyclic adenosine monophosphate (cAMP) promotes bone growth in human cells but inhibits osteogenesis in rodent models. This species-specific difference is crucial for developing clinical applications in bone regeneration.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Regenerative Medicine

Background:

  • Protein kinase A (PKA) activation by cyclic adenosine monophosphate (cAMP) was previously shown to promote osteogenesis in human mesenchymal stem cells (hMSCs).
  • Translating these findings to clinical applications requires understanding species-specific responses and validating results in animal models.

Purpose of the Study:

  • To investigate the role of PKA activators, specifically N6,2'-O-dibutyryl-cAMP (db-cAMP) and 8-bromo cAMP (8b-cAMP), in rodent cell types and compare their effects to hMSCs.
  • To assess the species-specific osteogenic and adipogenic differentiation potential of cAMP in preclinical models.

Main Methods:

  • Treatment of MC3T3-E1 cells, mouse calvarial osteoblasts, mouse mesenchymal stem cells (MSCs), and rat MSCs with cAMP and its analogs (db-cAMP, 8b-cAMP).
  • Evaluation of osteogenic markers, including alkaline phosphatase (ALP), osteocalcin (BGLAP), and collagen type 1 (COL1A1).
  • Ex vivo culture of mouse calvaria treated with db-cAMP to assess bone volume changes.

Main Results:

  • cAMP significantly inhibited osteogenesis in all tested rodent cell types, indicated by reduced expression of key osteogenic markers.
  • Ex vivo treatment of mouse calvaria with db-cAMP led to a decrease in bone volume.
  • In rat MSCs, cAMP treatment stimulated adipogenic differentiation, suggesting a shift in cell fate.

Conclusions:

  • Contrary to findings in hMSCs, cAMP inhibits osteogenesis in vitro and bone formation ex vivo in rodent models.
  • Significant species discrepancies exist in cellular responses to cAMP-mediated PKA activation, highlighting the need for testing in clinically relevant models.
  • Understanding these species-specific differences is critical for the successful translation of fundamental research into clinical bone regeneration therapies.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...